Abstract

Immunoglobulin G4-related disease is an immune-mediated condition comprised of a number of various disorders sharing unique pathologic, serologic, and clinical features. Diagnosis of immunoglobulin G4-related sclerosing mastitis is challenging as the clinical and imaging findings mimic breast malignancies or other types of inflammatory mastitis. Herein, we describe a case of a female patient with a painless palpable mass in her right breast. An excisional core biopsy led to the rare diagnosis of immunoglobulin G4-related sclerosing mastitis, and the patient received steroid treatment for a month. To date, the patient has remained disease-free without any recurrence. As immunoglobulin G4-related sclerosing mastitis is a very rare disease, further studies are needed to reach conclusions about the pathogenesis, diagnosis, and treatment of this entity.

Introduction

Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition comprised of a number of various disorders sharing unique pathologic, serologic, and clinical features [1]. IgG4-RD can mimic a variety of different malignant, infectious, and inflammatory disorders, and it can affect one or multiple organs [2]. In the past, these diseases were regarded as isolated disorders whose pathophysiology was unknown [3, 4]. Over the past 20 years, a number of previously misdiagnosed cases have been newly diagnosed as IgG4-RD based on improved knowledge of this condition. The majority of IgG4-RD presents with tumor-like swelling of the affected organ, but diagnosis can be clinically difficult unless histopathologic findings include a lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells in the affected tissues [5]. Elevated serum concentrations of IgG4 are found in the majority of IgG4-RD patients [6, 7]. One of the IgG4-RDs is sclerosing mastitis, one of the rarest sub-forms of this group of diseases.

Herein, we describe the case of a female patient with a painless palpable mass in her right breast. Excisional core biopsy leads to the rare diagnosis of IgG4-related sclerosing mastitis (IgG4-RSM).

Case presentation

A 40-year-old female presented with a painless mass and skin lesions in the right breast and concurrent skin lesions in her left arm. Her prior medical history was unremarkable. She had never smoked or consumed alcohol. She had never received hormonal therapy. This was the first time she felt a mass in her breasts.

Upon palpation, a mass could be felt in the upper medial quadrant of the right breast. The overlying skin was intact, and the form and size of the affected breast were approximately equal to those of the contralateral breast. The examination of the axilla was unremarkable. Complete blood count and basic biochemistry reports were unremarkable, apart from slightly elevated liver enzymes.

Mammograms were obtained, but they did not report any pathological findings (Fig. 1). Right breast ultrasound (US) reported fibrocystic disease and a cystic mass of 9.5 mm in diameter located at 11 o’clock, which was larger than the rest of the existing cysts (Fig. 2). Breast elastography reported oedema, diffuse thickening of the skin, and an increase in the vasculature of the upper medial quadrant of the right breast. No cystic or solid mass was reported. Additionally, an enlarged lymph node, 21 × 6 mm in size, was reported to be located in the right axilla. This lymph node had an echogenic medulla and an enlarged cortex.

Right breast mammogram without pathological findings: (A) right craniocaudal (RCC) view and (B) right mediolateral (ML) view.
Figure 1

Right breast mammogram without pathological findings: (A) right craniocaudal (RCC) view and (B) right mediolateral (ML) view.

Right breast US findings. (A–C) Fibrocystic disease with cysts.
Figure 2

Right breast US findings. (A–C) Fibrocystic disease with cysts.

Due to the above findings, computed tomography (CT) (Fig. 3) and magnetic resonance imaging (MRI) were obtained. An MRI reported an area of 9.6 × 5 × 7.3 mm in the right breast enhanced by contrast uptake. The process infiltrated a segment of the overlying skin, and the MRI was labeled as Breast Imaging Reporting and Data System (BIRADS) category 4C (Fig. 4); therefore, a biopsy was requested.

CT indicating heterogeneous enhancement and diffuse thickening of the skin of the right breast.
Figure 3

CT indicating heterogeneous enhancement and diffuse thickening of the skin of the right breast.

Magnetic resonance imaging reporting an area of 9.6 × 5 × 7.3 mm in the right breast enhanced by contrast uptake: (A) T1-weighted sequence and (B) T2-weighted sequence.
Figure 4

Magnetic resonance imaging reporting an area of 9.6 × 5 × 7.3 mm in the right breast enhanced by contrast uptake: (A) T1-weighted sequence and (B) T2-weighted sequence.

As a fine needle aspiration (FNA) biopsy represents a rapid and low-cost alternative with high sensitivity and specificity to core biopsy [8], it was performed initially, and the findings were negative for malignancy. Because of the high suspicion of malignancy and the fact that core biopsy is associated with tumor cell seeding [9], an excisional biopsy was obtained. The result was negative for malignancy. Histopathology was positive for lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells, storiform fibrosis, prominent stromal sclerosis, and loss of breast lobules. Obliterative phlebitis was also present. An excision biopsy confirmed the diagnosis of IgG4-RSM. Actually, sections stained with hematoxylin and eosin (H + E) showed breast parenchyma with atrophic lobules and dense lymphoplasmacytic infiltration within or around them. The inflammatory cells were mainly T- and B-lymphocytes [CD3(+) and CD20(+), respectively], plasmacytes [CD18(+)], and fewer histiocytes. There was also stromal fibrosis, focally with a storiform pattern around the ducts, while the wall of some veins was invaded by the inflammatory cells, resulting in obliterative lesions. Immunohistochemically, there were many IgG(+) and IgG4(+) plasmacytes. Actually, there were 93 IgG4(+) plasmacytes per high power field (HPF) with the highest positive cells (>50), and the ratio of IgG4(+)/IgG(+) cells was 84% (>40%) (Fig. 5). The aforementioned histopathological findings were highly suggestive of IgG4-RSM. Serum IgG4 levels were 73 mg/dl.

Histopathological findings, highly suggestive of IgG4-related sclerosing mastitis (IgG4-RSM): (A) Atrophic lobule with dense lymphoplasmacytic infiltration (original magnification ×200); (B) dense lymphoplasmacytic infiltration in the adipose tissue (original magnification ×400); (C) many IgG(+) plasmatocytes (original magnification ×400); and (D) more than 50 IgG4(+) plasmatocytes in this HPF (original magnification ×400).
Figure 5

Histopathological findings, highly suggestive of IgG4-related sclerosing mastitis (IgG4-RSM): (A) Atrophic lobule with dense lymphoplasmacytic infiltration (original magnification ×200); (B) dense lymphoplasmacytic infiltration in the adipose tissue (original magnification ×400); (C) many IgG(+) plasmatocytes (original magnification ×400); and (D) more than 50 IgG4(+) plasmatocytes in this HPF (original magnification ×400).

Twenty days after the mass excision, the skin lesions persisted (Fig. 6), so the patient was treated with steroids for the duration of a month. Five years after the diagnosis, she remains disease-free without any recurrence.

Since the mass excision, the skin lesions persisted: (A) right breast 20 days postoperatively and (B) left arm.
Figure 6

Since the mass excision, the skin lesions persisted: (A) right breast 20 days postoperatively and (B) left arm.

Discussion

IgG4-RSM represents a rare member of the expanding IgG4-RD family. Diagnosis of IgG4-RSM is challenging as the clinical and imaging findings mimic breast malignancies or other types of inflammatory mastitis. Despite the lack of approved histopathological correlates specific to breast IgG4-RD, a biopsy is necessary for the diagnosis. As IgG4-RSM is a very rare disease, further studies are needed to understand the pathogenesis, diagnosis, and treatment of this entity.

Author contributions

Loukia Koutsogeorgopoulou: provided the clinical input to the case; Christos Damaskos: provided the clinical input to the case and wrote the manuscript; Nikolaos Garmpis: provided the clinical input to the case and wrote the manuscript; Eleni I. Effraimidou: offered scientific advice and critically revised the manuscript; Iason Psilopatis: revised the manuscript; Anna Garmpi: performed literature search and collected the data; Kleio Vrettou: performed cytological evaluation; Konstantinos Nikolettos: performed literature search and collected the data; Afroditi Nonni: was the supervisor and performed histopathological evaluation.

Funding

None declared.

References

1.

Stone
JH
,
Zen
Y
,
Deshpande
V
.
IgG4-related disease
.
N Engl J Med
 
2012
;
366
:
539
51
.

2.

Kamisawa
T
,
Zen
Y
,
Pillai
S
, et al.   
IgG4-related disease
.
Lancet
 
2015
;
385
:
1460
71
.

3.

Kamisawa
T
,
Funata
N
,
Hayashi
Y
, et al.   
A new clinicopathological entity of IgG4-related autoimmune disease
.
J Gastroenterol
 
2003
;
38
:
982
4
.

4.

Khosroshahi
A
,
Stone
JH
.
A clinical overview of IgG4-related systemic disease
.
Curr Opin Rheumatol
 
2011
;
23
:
57
66
.

5.

Deshpande
V
,
Zen
Y
,
Chan
JK
, et al.   
Consensus statement on the pathology of IgG4-related disease
.
Mod Pathol
 
2012
;
25
:
1181
92
.

6.

Carruthers
MN
,
Khosroshahi
A
,
Augustin
T
, et al.   
The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
.
Ann Rheum Dis
 
2015
;
74
:
14
8
.

7.

Cheuk
W
,
Chan
JK
.
IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity
.
Adv Anat Pathol
 
2010
;
17
:
303
32
.

8.

Mitra
S
,
Dey
P
.
Fine-needle aspiration and core biopsy in the diagnosis of breast lesions: a comparison and review of the literature
.
Cytojournal
 
2016
;
13
:
18
.

9.

Maseki
H
,
Jimbo
K
,
Watase
C
, et al.   
Clinical significance of tumor cell seeding associated with needle biopsy in patients with breast cancer
.
Asian J Surg
 
2023
;
46
:
3700
4
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.